Your browser doesn't support javascript.
loading
How are children who are delayed in the Childhood Vaccination Programme vaccinated: A nationwide register-based cohort study of Danish children aged 15-24 months and semi-structured interviews with vaccination providers.
Pedersen, Kenneth B; Holck, Marie E; Jensen, Aksel K G; Suppli, Camilla H; Benn, Christine S; Krause, Tyra G; Sørup, Signe.
Afiliação
  • Pedersen KB; Research Center for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, Denmark.
  • Holck ME; OPEN, Institute of Clinical Research, University of Southern Denmark and Odense University Hospital, Denmark.
  • Jensen AKG; Research Center for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, Denmark.
  • Suppli CH; OPEN, Institute of Clinical Research, University of Southern Denmark and Odense University Hospital, Denmark.
  • Benn CS; Research Center for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, Denmark.
  • Krause TG; Section of Biostatistics, University of Copenhagen, Denmark.
  • Sørup S; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Denmark.
Scand J Public Health ; 48(1): 96-105, 2020 Feb.
Article em En | MEDLINE | ID: mdl-30024308
Aims: Delay of childhood vaccinations is common and influences efforts to reduce targeted diseases. In Denmark, the diphtheria, tetanus, pertussis, polio and Haemophilus influenzae type b (DTaP-IPV-Hib) vaccine is recommended at ages 3, 5 and 12 months and the first measles-mumps-rubella vaccine (MMR-1) at 15 months. Following guidelines, children delayed at age 15 months should receive MMR-1 and DTaP-IPV-Hib-3 simultaneously, unless DTaP-IPV-Hib-2 was received less than 6 months ago, when MMR-1 alone is recommended. We studied compliance with these guidelines and the reasons for non-compliance with a focus on vaccination providers. Methods: We used a nationwide register-based cohort study of children born in Denmark between January 2000 and June 2013, who were lacking MMR-1 and DTaP-IPV-Hib-3 at age 15 months and were followed to 24 months. We also performed semi-structured telephone interviews with vaccination providers. Results: The study consisted of 156,921 children (18% of the children born in the period). Among the 40,060 children who had received DTaP-IPV-Hib-2 less than 6 months ago, 37,892 (95%) received MMR-1 alone. Among the 88,469 children who had received DTaP-IPV-Hib-2 more than 6 months ago, 6334 (7%) received DTaP-IPV-Hib-3 and MMR-1 simultaneously. The interviews indicated that some vaccination providers are reluctant to give multiple vaccinations at the same visit and some have a preference of following the usual sequence in the programme. Conclusions: Vaccination providers generally complied with the recommended minimum 6 months' interval between DTaP-IPV-Hib-2 and DTaP-IPV-Hib-3. Conversely, there was a low compliance with the recommendation to administer DTaP-IPV-Hib-3 and MMR-1 simultaneously. More efforts are needed to ensure timely vaccination.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Vacinação / Pessoal de Saúde / Programas de Imunização Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Qualitative_research / Risk_factors_studies Limite: Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Vacinação / Pessoal de Saúde / Programas de Imunização Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Qualitative_research / Risk_factors_studies Limite: Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article